Amino acids with fluorescent tetrazine ethers as bioorthogonal handles for peptide modification. 2022

Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology Baldiri Reixac 10 08028 Barcelona Spain antoni.riera@irbbarcelona.org.

A set of 3-bromo-1,2,4,5-tetrazines with three distinct substitutions have been used as reagents for late-stage functionalization of small molecules through nucleophilic aromatic substitution. Spectroscopic studies of the products obtained proved that tetrazine ethers are intrinsically fluorescent. This fluorescence is lost upon inverse Electron-Demand Diels-Alder (iEDDA) cycloaddition with strained alkenes. Tetrazine-phenol ethers are rather interesting because they can undergo rapid iEDDA reactions with a second order rate constant (k 2) compatible with bioorthogonal ligations. As a showcase, l-tyrosine was derivatized with 3-bromo-6-methyl-1,2,4,5-tetrazine and coupled to the peptide drug octreotide. This peptide was detected in cellular flow cytometry, and its fluorescence turned off through a bioorthogonal iEDDA cycloaddition with a strained alkene, showing for the first time the detection and reactivity of intrinsically fluorescent tetrazines in a biologically relevant context. The synthesis and characterization of fluorescent tetrazine ethers with bioorthogonal applicability pave the way for the generation of useful compounds for both detection and bioconjugation in vivo.

UI MeSH Term Description Entries

Related Publications

Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
April 2018, Bioconjugate chemistry,
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
January 2015, PloS one,
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
July 2022, Organic letters,
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
October 2022, Natural sciences (Weinheim, Germany),
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
November 2010, Amino acids,
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
January 2018, Journal of the American Chemical Society,
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
January 2021, Bioconjugate chemistry,
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
July 2023, Journal of the American Chemical Society,
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
January 2018, Methods in molecular biology (Clifton, N.J.),
Enric Ros, and Marina Bellido, and Joan A Matarin, and Albert Gallen, and Manuel Martínez, and Laura Rodríguez, and Xavier Verdaguer, and Lluís Ribas de Pouplana, and Antoni Riera
January 2019, Communications biology,
Copied contents to your clipboard!